Table 2.
Clinician questions/responses,2 (T/F) | Correct, % | Incorrect or Unsure, % | Missing, % |
---|---|---|---|
Most HPV infections resolve without medical intervention (T) | 82.1 | 16.5 | 1.4 |
Treatment of cervical dysplasia/cancer permanently eliminates the causative infection (F) | 91.4 | 7.9 | 0.7 |
Genital warts are caused by the same HPV types that cause cervical cancer (F) | 60.4 | 38.9 | 0.7 |
Almost all cervical cancers are caused by HPV infection (T) | 92.9 | 6.7 | 0.4 |
The ACIP, CDC, ACP, ACOG, AAFP, and AAP recommend the bivalent, quadrivalent, and nonavalent HPV vaccine for all females ages 11 to 26 years with permission to start at 9 to 10 years of age (T) | 93.6 | 6.0 | 0.4 |
The ACIP, CDC, ACP, ACOG, AAFP, and AAP recommend the quadrivalent and nonavalent HPV vaccine for all males ages 11 to 21 years with permission to start at 9 to 10 years of age and for males at high risk or seeking immunity 22 to 26 years of age (T) | 90.4 | 8.9 | 0.7 |
Females who have been diagnosed with HPV infection should not be given the HPV vaccine (F) | 91.4 | 8.2 | 0.4 |
Males who have been diagnosed with HPV infection should not be given the HPV vaccine (F) | 90.7 | 8.9 | 0.4 |
HPV causes vulvar, vaginal, and anal cancers in women (T) | 91.8 | 7.8 | 0.4 |
HPV causes anal cancers in men (T) | 95.4 | 4.2 | 0.4 |
HPV causes head and neck cancers (T) | 81.8 | 17.8 | 0.4 |
N=280
Correct response is shown in True/False (T/F)
Abbreviations: AAFP, American Academy of Family Physicians; AAP, American Academy of Pediatrics; ACIP, Advisory Committee on Immunization Practices; ACOG, American Congress of Obstetricians and Gynecologists; ACP, American College of Physicians; CDC, Centers for Disease Control and Prevention; HPV, Human Papillomavirus